Joseph Spernyak, PhD

Preclinical Imaging Facility and Imaging Research Scientist
Roswell Park Cancer Institute

Dr. Spernyak has been involved in a broad range of research projects incorporating the use of magnetic resonance imaging (MRI) for studying small animal model of disease. His recent interests have focused primarily in three areas, a) development and assessment of novel MRI/PDT contrast agents for the purpose of combining imaging and therapy within a single compound, b) use of MRI to non-invasively characterize changes in tumor microvasculature arising from anti-cancer therapies, and c) application of balanced, steady-state free precession imaging for efficient and accurate measurement of tissue MR relaxation rates.

Research Interests: 
Magnetic resonance imaging in animal models of disease
E-mail Address:
Phone Number: